Latest Articles

Article Type

You have access
Substituted Cysteine Modification and Protection with n-Alkyl-MTS Reagents Quantifies Steric Changes Induced by a Mutation in Anesthetic Binding Sites on GABA Type A Receptors
Kieran Bhave and Stuart A. Forman

Molecular Pharmacology August 16, 2023, MOLPHARM-AR-2023-000719; DOI: https://doi.org/10.1124/molpharm.123.000719
You have access
Gα protein signaling bias at 5-HT1A receptor
Rana Alabdali, Luca Franchini and Cesare Orlandi

Molecular Pharmacology August 11, 2023, MOLPHARM-AR-2023-000722; DOI: https://doi.org/10.1124/molpharm.123.000722
You have access
Thermogenic modulation of adipose depots: A perspective on possible therapeutic intervention with early cardiorenal complications of metabolic impairment
Ahmed F El-Yazbi, Mohamed A. Elrewiny, Hosam M Habib, Ali H. Eid, Perihan A Elzahhar and Ahmed SF Belal

Molecular Pharmacology August 11, 2023, MOLPHARM-EMC-2023-000704; DOI: https://doi.org/10.1124/molpharm.123.000704
You have access
Role of Conserved Tyrosine Lid Residues in the Activation of the M₂ Muscarinic Acetylcholine Receptor
Vi Pham, Maria Clazina Cornelia Habben Jansen, Geoff Thompson, Laura H. Heitman, Arthur Christopoulos, David M. Thal and Celine Valant

Molecular Pharmacology September 2023, 104 (3) 92-104; DOI: https://doi.org/10.1124/molpharm.122.000661
You have access
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor
Gernot Langer, John Scott, Christoffer Lind, Christiane Otto, Ulrich Bothe, Alexis Laux-Biehlmann, Jörg Müller, Beau le Roy, Horst Irlbacher, Katrin Nowak-Reppel, Anne Schlüter, Adam J. Davenport, Mark Slack and Stefan Bäurle

Molecular Pharmacology September 2023, 104 (3) 105-114; DOI: https://doi.org/10.1124/molpharm.122.000662
Open Access
EP4 Receptor Conformation Sensor Suited for Ligand Screening and Imaging of Extracellular Prostaglandins
Michael Kurz, Michaela Ulrich, Alwina Bittner, Magdalena Martina Scharf, Jingchen Shao, Imke Wallenstein, Horst Lemoine, Nina Wettschureck, Peter Kolb and Moritz Bünemann

Molecular Pharmacology September 2023, 104 (3) 80-91; DOI: https://doi.org/10.1124/molpharm.122.000648
You have access
Chemical, Pharmacological, and Structural Characterization of Novel Acrylamide-Derived Modulators of the GABA_A Receptor
Hugo R. Arias, Spencer R. Pierce, Allison L. Germann, Sophia Q. Xu, Marcelo O. Ortells, Seiji Sakamoto, Dina Manetti, Maria Novella Romanelli, Itaru Hamachi and Gustav Akk

Molecular Pharmacology September 2023, 104 (3) 115-131; DOI: https://doi.org/10.1124/molpharm.123.000692
You have access
Amyloid-beta peptides 40 and 42 employ distinct molecular pathways for cell entry and intracellular transit at the blood-brain barrier (BBB) endothelium
Zengtao Wang, Nidhi Sharda, Rajesh S. Omtri, Ling Li and Karunya K. Kandimalla

Molecular Pharmacology August 4, 2023, MOLPHARM-AR-2023-000670; DOI: https://doi.org/10.1124/molpharm.123.000670
You have access
The Potential Antidepressant Compound Org 34167 Modulates HCN Channels Via a Novel Mode of Action
Chaseley E. McKenzie, Andrew Hung, A. Marie Phillips, Ming S. Soh, Christopher A. Reid and Ian C. Forster

Molecular Pharmacology August 2023, 104 (2) 62-72; DOI: https://doi.org/10.1124/molpharm.123.000676
Open Access
A Point Mutation at C151 of Keap1 of Mice Abrogates NRF2 Signaling, Cytoprotection in Vitro, and Hepatoprotection in Vivo by Bardoxolone Methyl (CDDO-Me)
Tonibelle Gatbonton-Schwager, Yoko Yagishita, Tanvi Joshi, Nobunao Wakabayashi, Harini Srinivasan, Takafumi Suzuki, Masayuki Yamamoto and Thomas W. Kensler

Molecular Pharmacology August 2023, 104 (2) 51-61; DOI: https://doi.org/10.1124/molpharm.123.000671

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals